Skip to content

Medical-device intelligence

Visionsense, Ltd.: FDA clearances and recalls

Research Visionsense, Ltd. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

13 clearance records and 4 recall records in the covered releases, across 1 source company names and 6 product codes. Dated history runs from Mar 5, 2008 to Oct 28, 2022.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

17 matching records
Device / recordCompany in FDA recordSourceSource date
VS3 Iridium Visionsense Infrared (IR) Fluorescence Miniature Microscope (MMS-IR) Product Number: 174-0012Z-0280-2023 · OWNVisionsense, Ltd.RecallNov 23, 2022FDA classification date
VS3 Iridium - Visionsense Infrared (IR) Fluorescence Miniature Microscope (MMS) - 785nm Product Number: 175-0012Z-0281-2023 · OWNVisionsense, Ltd.RecallNov 23, 2022FDA classification date
VS3 Iridium Visionsense Infrared (IR) Fluorescence Light Integrator (Beam Combiner) Product Number: 161-0001Z-0282-2023 · OWNVisionsense, Ltd.RecallNov 23, 2022FDA classification date
VS3-Iridium System (VS3-IR)K223020 · OWNVisionsense, Ltd.510(k)Oct 28, 2022FDA decision date
VS3 Iridium SytemK210265 · OWNVisionsense, Ltd.510(k)Nov 22, 2021FDA decision date
Trans-anal IntroducerK171208 · FEDVisionsense, Ltd.510(k)Feb 5, 2018FDA decision date
VS3 STEREOSCOPIC HIGH DEFINITION VISION SYSTEMK153548 · HRXVisionsense, Ltd.510(k)Feb 22, 2016FDA decision date
VS3-IR systemK152204 · OWNVisionsense, Ltd.510(k)Oct 28, 2015FDA decision date
VS3-IR-MMS SystemK150018 · OWNVisionsense, Ltd.510(k)Jun 17, 2015FDA decision date
VS3 STEREOSCOPIC HIGH DEFINITION VISION SYSTEMK141002 · HRXVisionsense, Ltd.510(k)Jun 26, 2014FDA decision date
VS3 STEREOSCOPIC HIGH DEFINITION VISION SYSTEMK131434 · GWGVisionsense, Ltd.510(k)Jul 16, 2013FDA decision date
VS3K123467 · GCJVisionsense, Ltd.510(k)Apr 17, 2013FDA decision date
Visionsense Stereoscopic Vision System, Brand name VSII, Model/Part Numbers 172-0030 and 172-0040 --- Classification Name: Neurological Endoscope…Z-1192-2012 · GWGVisionsense, Ltd.RecallMar 8, 2012FDA classification date
VISIONSENSE STEREOSCOPIC VISION SYSTEMK082355 · HRXVisionsense, Ltd.510(k)Dec 15, 2008FDA decision date
VISIONSENSE STEREOSCOPIC VISION SYSTEM (VS SYSTEM)K082667 · EOBVisionsense, Ltd.510(k)Oct 30, 2008FDA decision date
VSU - VISIONSENSE STEREOSCOPIC VISION SYSTEMK081102 · GWGVisionsense, Ltd.510(k)May 29, 2008FDA decision date
VS-VISIONSENSE STEREOSCOPIC VISION SYSTEMK073279 · GCJVisionsense, Ltd.510(k)Mar 5, 2008FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗